NATURAL ALTERNATIVES INTERNATIONAL INC Line of Credit Facility, Current Borrowing Capacity
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) had Line of Credit Facility, Current Borrowing Capacity of $5.50 million as of 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity · last filed 2015-11-12
- 2015-09-30: Line of Credit Facility, Current Borrowing Capacity $5.50M.
- 2015-06-30: Line of Credit Facility, Current Borrowing Capacity $5.50M.
- 2015-03-31: Line of Credit Facility, Current Borrowing Capacity $5.50M.
- 2014-12-31: Line of Credit Facility, Current Borrowing Capacity $5.50M.
| Period end | Line of Credit Facility, Current Borrowing Capacity | Line of Credit Facility, Current Borrowing Capacity as first filed |
|---|---|---|
| 2015-09-30 | $5.50M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $5.50M 10-K · filed 2015-09-18 | |
| 2015-03-31 | $5.50M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $5.50M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $5.50M 10-Q · filed 2014-11-12 | |
| 2013-12-31 | $5.60M 10-Q · filed 2014-02-12 | |
| 2013-09-30 | $5.60M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $5.60M 10-K · filed 2014-09-25 | $5.50M 10-K · filed 2013-09-19 |
| 2013-03-31 | $5.60M 10-Q · filed 2014-05-13 | $5.50M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $5.50M 10-Q · filed 2013-02-12 | |
| 2012-09-30 | $5.50M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $5.50M 10-K · filed 2012-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |